Materialise misses top-line and bottom-line estimates; reaffirms FY26 outlook

Materialise (MTLS) reported Q2 2026 revenue of €70.1M, up 8.1% YoY, with adjusted EBITDA rising 15.7%. Aerospace and defense demand drove Manufacturing segment growth, while Medical remained the fastest-growing business. The company raised its profitability outlook for 2026.

MATERIALISE NV (MTLS) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Materialise reports second quarter and half-year 2026 results Regulated information 1 LEUVEN, Belgium--(BUSINESS WIRE)—August 27, 2026 -- Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive ma

Materialise NV reported Q2 2026 revenue of 70,073 kEUR, up 8.1% YoY. Adjusted EBITDA rose 15.7% to 9,593 kEUR, and net profit increased to 3,331 kEUR. Medical segment revenue grew 12.2%, while Software segment revenue declined 2.7%. H1 2026 revenue was 136,349 kEUR, up 3.9% YoY, with adjusted EBITDA up 22.2% to 17,642 kEUR.

Endesa SA reported higher earnings and revenue for the first nine months of 2026. Net income rose to EUR 1.962 billion from EUR 1.711 billion a year ago. The company reaffirmed its annual ordinary net profit outlook of over EUR 2.400 billion for 2026.

Hilton raised its 2026 RevPAR growth forecast to 4-4.5% due to strong US and luxury hotel demand, despite Q3 revenue of $3.33B missing estimates. Adjusted EPS beat expectations at $2.45. Regional performance varied, with the US up 7% and the Middle East down 5.6%.

The FTSE 100 fell 0.30% as investors awaited the UK budget and reacted to earnings from GSK and Unilever. GSK dropped 4.3% despite beating Q3 expectations, while Unilever fell 3.38% after raising its volume growth forecast. The UK finance minister announced the scrapping of gas standing charges. Brent and WTI oil prices rose, while gold prices declined.